Showing 25–36 of 116 results
-
Elahere
FreeElahere is indicated as a treatment for adult patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. These patients should havereceived one to three prior systemic treatment regimens.
The selection of patients for this therapy should be based on an FDA-approved test. Accelerated approval for this indication is based on tumor response rate and durability ofresponse. Continued approval may be contingent upon verification and description of clinicalbenefit in a confirmatory trial.
-
Elmiron
FreeTrade Name Elmiron Active Ingredient Pentosan Polysulfate Sodium Power 100mg Type / form Capsules Status NA Manufacturer Janssen  
-
Emend
FreeTrade Name Emend Active Ingredient Aprepitant Power 40mg /80mg/120mg Type / form Capsules Status NA Manufacturer MSD -
Enhertu
Free- Name: ENHERTU
- Generic Name: Trastuzumab Deruxtecan
- Dosage Form & Strength: For injection: 100 mg lyophilized powder in a single-dose vial
- Manufactured: Daiichi Sankyo, Inc.
-
Erleada
FreeTrade Name Erleada Active Ingredient Apalutamide Power 60 mg Type / form Tablets Status NA Manufacturer Janssen -
Esmeron
FreeTrade Name Esmeron Active Ingredient Rocuronium Bromide Power 50 mg Type / form Injection Status NA Manufacturer MSD -
-
Evrysdi
FreeTrade Name Evrysdi Active Ingredient Risdiplam Power 60 mg Type / form Oral Solution Status NA Manufacturer Roche -
-
Fetroja
FreeTrade Name Fetroja Active Ingredient Cefiderocol Power 1 gm Type / form Injection Status NA Manufacturer Shiongi C Co. -
Gavreto
FreeTrade Name Gavreto Active Ingredient Pralsetinib Power 100 mg Type / form Capsules Status NA Manufacturer Roche -
Gilenya
FreeTrade Name Gilenya Active Ingredient Fingolimod Power 0.50 mg Type / form Capules Status NA Manufacturer Novartis
